The Influence of Adjuvant Chemotherapy Dose Intensity on Five-Year Outcomes in Resected Colon Cancer: A Single Centre Retrospective Analysis

por Lakkunarajah, Suganija, Breadner, Daniel A., Zhang, Hanbo, Yamanaka, Ellen, Warner, Andrew, Welch, Stephen
Publicado 2021

First-line osimertinib for patients with EGFR-mutated advanced non-small cell lung cancer: efficacy and safety during the COVID-19 pandemic

por Lakkunarajah, Suganija, Truong, Pauline T., Bone, Jeffrey N., Hughesman, Curtis, Yip, Stephen, Alex, Deepu, Hart, Jason, Pollock, Philip, Egli, Sarah, Clarkson, Melissa, Lesperance, Mary, Ksienski, Doran
Publicado 2023

Real-World Analysis of Durvalumab after Chemoradiation in Stage III Non-Small-Cell Lung Cancer

por Preti, Beatrice T. B., Sanatani, Michael S., Breadner, Daniel, Lakkunarajah, Suganija, Scott, Carolyn, Esmonde-White, Caroline, McArthur, Eric, Rodrigues, George, Chaudhary, Mitali, Mutsaers, Adam, Sachdeva, Robin, Vincent, Mark D.
Publicado 2023

The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis

por Breadner, Daniel, Loree, Jonathan M., Cheung, Winson Y., Gipson, Meghan, Lakkunarajah, Suganija, Mulder, Karen E., Spartlin, Jennifer L., Kong, Shiying, Ding, Philip Q., Gill, Sharlene, Welch, Stephen A.
Publicado 2022